Plain-English translation of NCT06383013 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a Phase II trial testing , a topical (applied to skin) medication, to see if it can help heal diabetic foot and lower leg ulcers. Researchers want to understand whether the medication works better than a placebo (inactive treatment) and whether it's safe. You would receive standard wound care throughout the study, plus either the medication at a high dose, a low dose, or a placebo.
Diabetic foot ulcers can be difficult to heal and may lead to serious complications if left untreated. This study aims to find out whether this new topical treatment could offer patients a better option for healing these stubborn wounds.
You likely qualify if…
You likely don't qualify if…
You would visit the study site regularly over 4 weeks and apply the assigned treatment (high-dose medication, low-dose medication, or placebo) once daily to your ulcer. You'll continue receiving your regular ulcer care and diabetes management throughout the study. The research team will measure your ulcer's size and healing progress at each visit and monitor you for any side effects.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
Taiwan